Related references
Note: Only part of the references are listed.Abrupt withdrawal of cannabidiol (CBD): A randomized trial
Lesley Taylor et al.
EPILEPSY & BEHAVIOR (2020)
Predictors of Nabiximols (Sativex(R)) discontinuation over long-term follow-up: a real-life study
Antonio Carotenuto et al.
JOURNAL OF NEUROLOGY (2020)
What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio
Victoria Zeyl et al.
SUBSTANCE USE & MISUSE (2020)
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
Shlomo Almog et al.
EUROPEAN JOURNAL OF PAIN (2020)
Mapping cannabis potency in medical and recreational programs in the United States
Mary Catherine Cash et al.
PLOS ONE (2020)
A Balanced Approach for Cannabidiol Use in Chronic Pain
Donovan A. Argueta et al.
FRONTIERS IN PHARMACOLOGY (2020)
Medical cannabis in the UK: From principle to practice
Anne Katrin Schlag et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users
Jasmine Turna et al.
COMPREHENSIVE PSYCHIATRY (2020)
The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage
Kevin M. Takakuwa et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P. Freeman et al.
LANCET PSYCHIATRY (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Use of marijuana exclusively for medical purposes
Melanie M. Wall et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies
Ziva D. Cooper et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain
Brian E. Perron et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Higher average potency across the United States is associated with progression to first cannabis use disorder symptom
Brooke J. Arterberry et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
A prospective observational study of problematic oral cannabinoid use
Mark A. Ware et al.
PSYCHOPHARMACOLOGY (2018)
Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users
Mallory Loflin et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2018)
Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Age Differences in Daily and Nondaily Cannabis Use in the United States, 2002-2014
Pia M. Mauro et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2018)
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Alex Straiker et al.
MOLECULAR PHARMACOLOGY (2018)
The use of cannabis in response to the opioid crisis: A review of the literature
Marianne Beare Vyas et al.
NURSING OUTLOOK (2018)
Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability
Ruth Braidwood et al.
FRONTIERS IN PSYCHIATRY (2018)
Patient-Reported Symptom Relief Following Medical Cannabis Consumption
Sarah S. Stith et al.
FRONTIERS IN PHARMACOLOGY (2018)
Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis A Crossover Trial
Tory R. Spindle et al.
JAMA NETWORK OPEN (2018)
Lee Robins' studies of heroin use among US Vietnam veterans
Wayne Hall et al.
ADDICTION (2017)
Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients
Sebastian Schimrigk et al.
EUROPEAN NEUROLOGY (2017)
Use of Marijuana for Medical Purposes Among Adults in the United States
Wilson M. Compton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes
Ryan Vandrey et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2017)
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
Brian J. Piper et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)
Carrie Cuttler et al.
PLOS ONE (2017)
Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics
Sybil Goulet-Stock et al.
EUROPEAN ADDICTION RESEARCH (2017)
US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws 1991-1992 to 2012-2013
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2017)
Nonmedical Versus Medical Marijuana Use Among Three Age Groups of Adults: Associations With Mental and Physical Health Status
Namkee G. Choi et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
The Standard Joint Unit
Cristina Casajuana Kogel et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight
Ilina Singh et al.
LANCET PSYCHIATRY (2017)
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD
Mallory Loflin et al.
ADDICTIVE BEHAVIORS (2017)
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample
Lewei A. Lin et al.
ADDICTIVE BEHAVIORS (2016)
Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On
Barry J. Everitt et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 67 (2016)
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake
Matthew N. Newmeyer et al.
CLINICAL CHEMISTRY (2016)
Trends in registered medical marijuana participation across 13 US states and District of Columbia
Brian J. Fairman
DRUG AND ALCOHOL DEPENDENCE (2016)
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a NovelmTOR/p70S6Kinase Signaling Pathway
Justine Renard et al.
JOURNAL OF NEUROSCIENCE (2016)
Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran et al.
NATURE REVIEWS NEUROSCIENCE (2016)
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit
Chandni Hindocha et al.
FRONTIERS IN PSYCHIATRY (2016)
Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form
Marcel O. Bonn-Miller et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Smoking, vaping, eating: Is legalization impacting the way people use cannabis?
Jacob T. Borodovsky et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2016)
Sociodemographic and drug use severity differences between medical marijuana users and non-medical users visiting the emergency department
Susan I. Woodruff et al.
AMERICAN JOURNAL ON ADDICTIONS (2016)
Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal
D. J. Allsop et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
Chandni Hindocha et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
Michael H. Andreae et al.
JOURNAL OF PAIN (2015)
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
Mark S. Wallace et al.
JOURNAL OF PAIN (2015)
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
T. P. Freeman et al.
PSYCHOLOGICAL MEDICINE (2015)
Revisiting the role of the insula in addiction
Vita Droutman et al.
TRENDS IN COGNITIVE SCIENCES (2015)
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2015)
Are Medical Marijuana Users Different From Recreational Users? The View From Primary Care
Peter Roy-Byrne et al.
AMERICAN JOURNAL ON ADDICTIONS (2015)
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2015)
Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
Tom P. Freeman et al.
ADDICTION (2014)
Marijuana use and intoxication among daily users: An intensive longitudinal study
John R. Hughes et al.
ADDICTIVE BEHAVIORS (2014)
The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals With Chronic Noncancer Pain The Role of Opioid Prescription
Mark J. Edlund et al.
CLINICAL JOURNAL OF PAIN (2014)
Problems with the Identification of 'Problematic' Cannabis Use: Examining the Issues of Frequency, Quantity, and Drug Use Environment
Mark Asbridge et al.
EUROPEAN ADDICTION RESEARCH (2014)
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users
Marcel O. Bonn-Miller et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2014)
Metabolic Effects of Chronic Cannabis Smoking
Ranganath Muniyappa et al.
DIABETES CARE (2013)
Predicting the transition from frequent cannabis use to cannabis dependence: A three-year prospective study
Peggy van der Pol et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Barth Wilsey et al.
JOURNAL OF PAIN (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
Ziva D. Cooper et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
C. J. A. Morgan et al.
PSYCHOLOGICAL MEDICINE (2012)
The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences
Elizabeth C. Temple et al.
ADDICTION (2011)
Plasma Cannabinoid Pharmacokinetics following Controlled Oral Delta(9)-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
Erin L. Karschner et al.
CLINICAL CHEMISTRY (2011)
The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress
David J. Allsop et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
Catalina Lopez-Quintero et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
Philip Robson
EXPERT OPINION ON DRUG SAFETY (2011)
Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats
Eric Murillo-Rodriguez et al.
LIFE SCIENCES (2011)
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Rita Z. Goldstein et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Celia J. A. Morgan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Rimonabant-Induced Δ9-Tetrahydrocannabinol Withdrawal in Rhesus Monkeys: Discriminative Stimulus Effects and Other Withdrawal Signs
Jennifer L. Stewart et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Adverse effects of medical cannabinoids: a systematic review
Tongtong Wang et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Understanding the motivations for recreational marijuana use among adult Canadians
Geraint B. Osborne et al.
SUBSTANCE USE & MISUSE (2008)
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
D. T. Wade et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Is there a common molecular pathway for addiction?
EJ Nestler
NATURE NEUROSCIENCE (2005)
Self-administration of cannabinoids by experimental animals and human marijuana smokers
Z Justinova et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Review of the validity and significance of cannabis withdrawal syndrome
AJ Budney et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Death and dependence: current controversies over the selective serotonin reuptake inhibitors
DJ Nutt
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users
HV Curran et al.
PSYCHOPHARMACOLOGY (2002)
Share Paper
